Affluent Medical SA (EPA:AFME)

Market Cap	52.33M
Revenue (ttm)	5.35M
Net Income (ttm)	-14.74M
Shares Out	39.35M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,962
Average Volume	2,012
Open	1.300
Previous Close	1.300
Day's Range	1.300 - 1.350
52-Week Range	1.190 - 2.110
Beta	0.62
RSI	44.53
Earnings Date	May 1, 2025

About Affluent Medical

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: AFME

Financial Performance

In 2024, Affluent Medical's revenue was 5.35 million, an increase of 337.09% compared to the previous year's 1.22 million. Losses were -14.74 million, -5.84% less than in 2023.